Difference between revisions of "User:RahalMccall69"

From eplmediawiki
Jump to: navigation, search
(Fifth seed Bautista)
(FDA Approves Lumason As Ultrasound Imaging Agent - News - Headlines & Global News)
Line 1: Line 1:
 
@@@  
 
@@@  
Spanish fifth seed Roberto Bautista-Agut advanced to the second round of the Kremlin Cup on Monday thanks to a straight-sets victory over Russia s Andrey Kuznetsov.
+
"Sometimes echocardiograms in certain patients are difficult for physicians to see and interpret," said Libero Marzella, M.D., Ph.D., director of the Division of Medical Imaging Products in the FDA's Center for Drug Evaluation and Research, in a . "Today's approval provides doctors with another option when performing contrast enhanced ultrasound."<br>
  
At the ATP and WTA combined event in the Russian capital, Bautista-Agut, who suffered an opening round defeat in his maiden appearance in 2012, won 6-3, 6-4 in his first meeting against Kuznetsov to keep alive his slim chances of making it into the season-ending ATP World Tour Finals in London.
+
The safety and effectiveness of the drug was tested in three clinical trials, which included 191 patients. All of them had suspected cardiac disease and their echocardiograms were difficult to read and interpret.<br>
  
I feel good as I think I ve played a solid match. I returned well and also served well tonight, said world number 16 Bautista-Agut.
+
Researchers noted that in all three trials, doctors were able to clearly see the lining of the left ventricle. Lumason also aided in visual improvement observed in the majority of the patients who received a 2 milliliter dose of the agent.<br>
  
I have a lot of confidence after performing well in Shanghai and I m looking forward to the next match here.  
+
The ultrasound imaging agent comes with a boxed warning, alerting people of the risk of serious cardiopulmonary reactions, including fatal cardiac or respiratory arrest. The risk of these reactions is high among patients with certain heart conditions; most serious reactions occur within 30 minutes of administration.<br>
  
Meanwhile, Italy s eighth seed and 2012 winner Andreas Seppi reached the second round as he disposed of Serbia s Dusan Lajovic 7-5, 6-4.
+
The most commonly reported side effects associated with Lumason were headache and nausea.<br>
  
It was a good start, a good first-round win for me and I m happy about today s performance. Seppi said.
+
The agent is marketed by Bracco Diagnostics Inc., located in Monroe Township, NJ.<br><p>Related Articles:</p><ul><li><a href=http://www.louisvuittontassenkopen.com>Louis Vuitton Tassen Kopen</a></li><li><a href=http://www.louisvuittontassenkopen.com>Louis Vuitton</a></li><li><a href=http://www.louisvuittontassenkopen.com>Geodkoop Louis Vuitton</a></li></ul>
 
+
I have nice memories about my past experiences in Moscow after winning a title two years ago and being in the semi-finals last year.
+
 
+
In the women s event, two-time Grand Slam champion and fifth seed Svetlana Kuznetsova, barely broke sweat as she cruised into the next round when Czech Republic s Klara Koukalova retired after losing the first set 6-1.
+
 
+
The 29-year-old Russian, currently 26th in the world, looked in complete command from the start and broke twice to take the opening frame in 30 minutes.
+
 
+
After that the Czech veteran Koukalova, 32, retired blaming a viral illness for her withdrawal.
+
 
+
It wasn t bad at all to play a short match today, Kuznetsova said.
+
 
+
I always prefer to start the tournament from the very beginning as when you have an opening round bye it s sometimes hard to play against an opponent who has already adjusted to the surface and the arena.<p>Related Articles:</p><ul><li><a href=http://www.louisvuittontassenkopen.com/goedkoop-louis-vuitton-alma-12>Louis Vuitton Alma Tassen</a></li><li><a href=http://www.louisvuittontassenkopen.com/goedkoop-louis-vuitton-speedy-17>Louis Vuitton tassen Speedy</a></li><li><a href=http://www.louisvuittontassenkopen.com/goedkoop-louis-vuitton-portemonn-16>Louis Vuitton Portemonn</a></li></ul>
+

Revision as of 18:12, 29 October 2014

@@@ "Sometimes echocardiograms in certain patients are difficult for physicians to see and interpret," said Libero Marzella, M.D., Ph.D., director of the Division of Medical Imaging Products in the FDA's Center for Drug Evaluation and Research, in a . "Today's approval provides doctors with another option when performing contrast enhanced ultrasound."

The safety and effectiveness of the drug was tested in three clinical trials, which included 191 patients. All of them had suspected cardiac disease and their echocardiograms were difficult to read and interpret.

Researchers noted that in all three trials, doctors were able to clearly see the lining of the left ventricle. Lumason also aided in visual improvement observed in the majority of the patients who received a 2 milliliter dose of the agent.

The ultrasound imaging agent comes with a boxed warning, alerting people of the risk of serious cardiopulmonary reactions, including fatal cardiac or respiratory arrest. The risk of these reactions is high among patients with certain heart conditions; most serious reactions occur within 30 minutes of administration.

The most commonly reported side effects associated with Lumason were headache and nausea.

The agent is marketed by Bracco Diagnostics Inc., located in Monroe Township, NJ.

Related Articles:

Personal tools
Namespaces

Variants
Actions
Navigation
extras
Toolbox